Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Clinical trial NCT00676338 · COMPLETED
Trial details
- NCT number
- NCT00676338
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 820
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.